A reexamination of the role of clusterin as a complement regulator

Experimental Cell Research

Volumn 249, Issue 1, 1999, Pages 13-21

  Hochgrebe, Tim T ^a   Humphreys, David ^b   Wilson, Mark R ^b   Easterbrook Smith, Simon B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Alternative complement pathway; Classical complement pathway; Clusterin; GPI anchor

Indexed keywords

CLUSTERIN;

ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CYTOLYSIS; ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RABBIT; TARGET CELL;

MURINAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 0033602717     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4459     Document Type: Article

References (42)

1. Blaschuk O., Burdzy K., Fritz I. B. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 258:1983;7714-7720.
2. Burkey B. F., deSilva H. V., Harmony J. A. K. Intracellular processing of apolipoprotein J precursor to the mature heterodimer. J. Lipid Res. 32:1991;1039-1048.
3. Kirszbaum L., Sharpe J. A., Murphy B., d'Apice A. J., Classon B., Hudson P. J., Walker I. D. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: A link between the complement and reproductive systems. EMBO J. 8:1989;711-718.
4. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A. K., Brewer B. H., Strickland D. K., Argraves W. S. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270:1995;13070-13075.
5. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., Frangione B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293:1993;27-30.
6. Zheng G., Bachinsky D. R., Stamenkovic I., Strickland D. K., Brown D., Andres G., McCluskey R. T. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42:1994;531-542.
7. Murphy B. F., Kirzbaum L., Walker I. D., d'Apice A. J. SP-40,40, a newly identified normal human serum protein found in the sC5b-9 complex of complement and in the immune deposits of glomerulonephritis. J. Clin. Invest. 81:1988;1858-1864.
8. Jenne D. E., Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc. Natl. Acad. Sci. USA. 86:1989;7123-7127.
9. Choi N-H., Mazda T., Tomitam M. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol. Immunol. 26:1989;835-840.
10. Oda T., G. M., Pasinetti H. H., Osterburg C., Anderson S. A., Johnson, Finch C. E. Purification and characterization of brain clusterin. Biochem. Biophys. Res. Commun. 204:1994;1131-1136.
11. Murphy B. F., Saunders J. R., O'Byran M. K., Kirszbaum L., Walker I. D., d'Apice A. J. F. SP-40,40 is an inhibitor of C5b-6-initiated haemolysis. Int. Immunol. 1:1989;551-554.
12. Choi N-H., Nakano Y., Tobe T., Mazda T., Tomita M. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b- 9) of complement. Int. Immunol. 2:1990;413-417.
13. Law G. L., Griswold M. D. Activity and form of sulfated glycoprotein 2 (clusterin) from cultured Sertoli cells, testis, and epididymis of the rat. Biol. Reprod. 50:1994;669-679.
14. Saunders J. R., Aminian A., McRae J. L., O'Farrell K. A., Adam W. R., Murphy B. F. Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int. 45:1994;817-827.
15. Vakeva A., Laurila P., Meri S. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology. 80:1993;177-182.
16. Bozas S. E., Kirszbaum L., Sparrow R. L., Walker I. D. Several vascular complement inhibitors are present on human sperm. Biol. Reprod. 48:1993;503-511.
17. O'Byran M. K., Murphy B. F., Liu D. Y., Clarke G. N., Baker H. W. G. The use of anticlusterin monoclonal antibodies for the combined assessment of human sperm morphology and acrosome integrity. Hum. Reprod. 9:1994;1490-1496.
18. Sylvester S., Skinner M. K., Griswold M. D. A sulfated glycoprotein synthesised by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol. Reprod. 31:1984;1087-1011.
19. Tung P. S., Fritz I. B. Immunolocalization of clusterin in the ram testis, rete testis and excurrent ducts. Biol. Reprod. 33:1985;177-186.
20. Wilson M. R., Easterbrook-Smith S. B. Enzyme complex amplification (ECA) - A signal amplification method for use in enzyme immunoassays. Anal. Biochem. 209:1993;183-187.
21. Pruett S. B., Lackey A. Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells. Clin. Exp. Immunol. 69:1987;624-631.
22. Ezzell J. L., Parker C. J. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity. Scand. J. Immunol. 36:1992;79-87.
23. Wong P., Taillefer D., Lakins J., Pineault J., Chader G., Tenniswood M. Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur. J. Biochem. 221:1994;917-925.
24. Jenkins S. H., Stuart W. D., Bottoms L. A., Harmony J. A. K. Quantitation of plasma apolipoprotein J. Methods Enzymol. 263:1996;309-316.
25. Kitamura H., Nagano A., Kitano I. Hemolysis of normal human erythrocytes by autologous serum complement. Int. Arch. Allergy Immunol. 100:1993;209-214.
26. Milis L., Morris C. A., Sheehan M. C., Charlesworth J. A., Pussell B. A. Vitronectin-mediated inhibition of complement: Evidence for different binding sites for C5b-7 and C9. Clin. Exp. Immunol. 92:1993;114-119.
27. Zheng X., Saunders T. L., Camper S. A., Samuelson L. C., Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc. Natl. Acad. Sci. USA. 92:1995;12426-12430.
28. Tschopp J., Chonn A., Hertig S., French L. E. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J. Immunol. 151:1993;2159-2165.
29. McDonald J. F., Nelsestuen G. L. Potent inhibition of terminal complement assembly by clusterin: Characterization of its impact on C9 polymerization. Biochemistry. 36:1997;7467-7473.
30. Eddy A. A., Fritz I. B. Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. Kidney Int. 39:1991;247-252.
31. French L. E., Tschopp J., Schifferli J. A. Clusterin in renal tissue: Preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. Clin. Exp. Immunol. 88:1992;389-393.
32. Wilson M. R., Easterbrook-Smith S. B. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG. Biochim. Biophys. Acta. 1159:1992;319-326.
33. Burkey B. F., Stuart W. D., Harmony J. A. K. Hepatic apolipoprotein J is secreted as a lipoprotein. J. Lipid Res. 33:1992;1517-1526.
34. Gelissen I. C., Hochgrebe T., Wilson M. R., Easterbrook-Smith S. B., Jessup W., Dean R. T., Brown A. J. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: A potential anti-atherogenic function? Biochem. J. 331:1998;231-237.
35. Pankhurst G. J., Bennett C. A., Easterbrook-Smith S. B. Characterization of the heparin-binding properties of human clusterin. Biochemistry. 37:1998;4823-4830.
36. Partridge S. R., Baker M. S., Walker M. J., Wilson M. R. Clusterin, a putative complement regulator, binds to the cell surface ofStaphylococcus aureus. Infect. Immun. 64:1996;4324-4329.
37. Jenne D. E., Lowin B., Peitsch M. C., Boettcher A., Schmitz G., Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J. Biol. Chem. 266:1991;11030-11036.
38. Kelso G. J., Stuart W. D., Richter R. J., Furlong C. E., Jordan Starck T. C., Harmony J. A. K. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry. 33:1994;832-839.
39. Oda T., Wals P., Osterburg H. H., Johnson S. A., Pasinetti G. M., Morgan T. E., Rozovsky I., Stine W. B., Snyder S. W., Holzman T. F., Krafft G. A., Finch C. E. Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136:1995;22-31.
40. Akesson P., Sjoholm A. G., Bjorck L. Protein SIC, a novel extracellular protein ofStreptococcus pyrogenes. J. Biol. Chem. 271:1996;1081-1088.
41. de Silva H. V., Harmony J. A. K., Stuart W. D., Gil C. M., Robbins J. Apolipoprotein J: Structure and tissue distribution. Biochemistry. 29:1990;5380-5389.
42. Bhakdi S., Fassbender W., Hugo F., Carreno M-P., Berssteher C., Malasit P., Kazatchkine M. D. Relative inefficiency of terminal complement activation. J. Immunol. 141:1988;3117-3122.